Alterity Therapeutics Limited Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TWIN LAKES CAPITAL MANAGEMENT, LLC | 10/21/2025 | 139.26 K | $523.61 K | 2,250.35% | 1.12% |
| MORGAN STANLEY | 11/14/2025 | 68.68 K | $258.24 K | 17.81% | 0.55% |
| HB WEALTH MANAGEMENT, LLC | 10/23/2025 | 58.46 K | $219.81 K | 100.00% | 0.47% |
| GREENLEAF TRUST | 10/22/2025 | 32.00 K | $120.32 K | 88.24% | 0.26% |
| CITADEL ADVISORS LLC | 11/14/2025 | 22.14 K | $83.48 K | 100.00% | 0.18% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 7.31 K | $27.48 K | -10.76% | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 4.80 K | $18.00 K | 100.00% | 0.04% |
| RHUMBLINE ADVISERS | 11/06/2025 | 886 | $3.34 K | 581.54% | 0.01% |
| CITIGROUP INC | 11/10/2025 | 636 | $2.40 K | 100.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 181 | $889 | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 177 | $666 | -71.82% | 0.00% |
| RONALD BLUE TRUST, INC. | 10/16/2025 | 40 | $150 | 0.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 10/14/2025 | 22 | $83 | 100.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/12/2025 | 6 | $23 | 0.00% | 0.00% |
| DANSKE BANK A/S | 11/19/2025 | 1 | $4 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 1 | $4 | 100.00% | 0.00% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Alterity Therapeutics Limited institutional Ownership - FAQ's
During the previous two years, 20 institutional investors and hedge funds held shares of Alterity Therapeutics Limited. The most heavily invested institutionals were:
Twin Lakes Capital Management, LLC: 139,258
MORGAN STANLEY: 68,682
HB Wealth Management, LLC: 58,460
GREENLEAF TRUST: 32,000
CITADEL ADVISORS LLC: 22,144
BNP PARIBAS ARBITRAGE, SNC: 7,309
2.68% of Alterity Therapeutics Limited stock is owned by institutional investors.
Institutional investors have bought a total of 338.44 K shares in the last 24 months. This purchase volume represents approximately $1.43 M in transactions.